• bitcoinBitcoin(BTC)$77,139.00-1.07%
  • ethereumEthereum(ETH)$2,269.09-0.98%
  • tetherTether(USDT)$1.00-0.04%
  • binancecoinBNB(BNB)$698.31-1.03%
  • rippleXRP(XRP)$1.281.94%
  • usd-coinUSDC(USDC)$1.00-0.03%
  • solanaSolana(SOL)$92.86-1.71%
  • tronTRON(TRX)$0.3222731.93%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.030.00%
  • zcashZcash(ZEC)$1,189.71-5.29%
  • HyperliquidHyperliquid(HYPE)$84.53-1.72%
  • moneroMonero(XMR)$622.472.06%
  • dogecoinDogecoin(DOGE)$0.074636-1.37%
  • USDSUSDS(USDS)$1.00-0.01%
  • whitebitWhiteBIT Coin(WBT)$74.15-1.10%
  • chainlinkChainlink(LINK)$11.16-1.72%
  • leo-tokenLEO Token(LEO)$9.27-1.34%
  • cardanoCardano(ADA)$0.190009-0.93%
  • stellarStellar(XLM)$0.164531-2.13%
  • bitcoin-cashBitcoin Cash(BCH)$276.75-0.53%
  • nearNEAR Protocol(NEAR)$3.87-6.59%
  • daiDai(DAI)$1.00-0.03%
  • Ethena USDeEthena USDe(USDE)$1.000.02%
  • RainRain(RAIN)$0.006228-1.19%
  • uniswapUniswap(UNI)$7.220.03%
  • litecoinLitecoin(LTC)$54.35-1.12%
  • CantonCanton(CC)$0.0965401.25%
  • USD1USD1(USD1)$1.000.05%
  • avalanche-2Avalanche(AVAX)$8.61-0.12%
  • suiSui(SUI)$0.89-0.05%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.15-3.77%
  • tether-goldTether Gold(XAUT)$3,900.240.07%
  • hedera-hashgraphHedera(HBAR)$0.070020-1.62%
  • quant-networkQuant(QNT)$198.56-1.23%
  • Global DollarGlobal Dollar(USDG)$1.00-0.01%
  • shiba-inuShiba Inu(SHIB)$0.000005-1.20%
  • paypal-usdPayPal USD(PYUSD)$1.000.00%
  • BittensorBittensor(TAO)$224.65-2.48%
  • Ripple USDRipple USD(RLUSD)$1.00-0.02%
  • crypto-com-chainCronos(CRO)$0.050265-1.06%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.150.02%
  • EthenaEthena(ENA)$0.171512-4.47%
  • okbOKB(OKB)$108.78-3.11%
  • Circle USYCCircle USYC(USYC)$1.140.01%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • pepePepe(PEPE)$0.000005-1.76%
  • aaveAave(AAVE)$128.16-2.64%
  • MemeCoreMemeCore(M)$0.850.31%
  • Pump.funPump.fun(PUMP)$0.0041871.42%
  • OndoOndo(ONDO)$0.387631-2.01%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Bill Ackman says Harvard not ‘entitled’ to federal funds

May 6, 2025
in Business
Reading Time: 3 mins read
A A
Bill Ackman says Harvard not ‘entitled’ to federal funds
ShareShareShareShareShare

Billionaire investor Bill Ackman on Tuesday said Harvard University, one of the nation’s oldest and wealthiest, should not be entitled to taxpayer funds when the school wastes money on what he calls “administrative bloat.”

YOU MAY ALSO LIKE

Macleods Pharma USA recalls thousands of blood pressure medication after pills fail quality test

Apple beats revenue expectations in first earnings report under new CEO John Ternus

Ackman, who earned undergraduate and business degrees from Harvard more than three decades ago, was speaking hours after the Trump administration said it was freezing future grants to Harvard.

He also criticized the school’s investment policies, saying the Ivy League university is facing a financial crisis and that its $53 billion endowment is “poorly invested.”

Bill Ackman criticized Harvard’s investment policies, saying the Ivy League university is facing a financial crisis and that its $53 billion endowment is “poorly invested.” REUTERS

“They have lost all future grants, their tax exemptions are at risk,” Ackman said on a panel at the Milken Institute Global Conference where 5,000 financiers, educators and scientists gather to discuss critical issues of the day.

“It is all self-induced gross mismanagement and I think that the (Trump) administration is doing precisely the right thing now,” Ackman told the packed room.

The Education Department informed Harvard on Monday that it was freezing billions of dollars in future research grants and other aid until the university concedes to a number of demands from the Trump administration, a senior department official said.

Harvard responded that the administration letter doubles down on demands that would impose “unprecedented and improper control” over the university and makes new threats to “illegally” withhold funding for lifesaving research.

“The notion is the federal government money is only going to fund breakthrough research, that is just false,” Ackman said.

Ackman earned undergraduate and business degrees from Harvard more than three decades ago. Above, the billionaire interviewed by Jeff Selingo, author at The Atlantic, on Tuesday. AFP via Getty Images

A representative for the university was not immediately available for comment and a representative for Harvard Management Company, which invests the endowment, declined to comment.

Ackman has long been at odds with Harvard, criticizing the university for not doing enough to protect students from antisemitism. Early last year he launched an unsuccessful bid to get four candidates on the ballot for a governing board.

The financier runs New York-based hedge fund firm Pershing Square Capital Management and has been a vocal supporter of Trump’s policies on tariffs and spending. Harvard is “a collection of buildings, nice real estate” located in Cambridge, Mass., next to the Charles River, he said.

Ackman has long been at odds with Harvard, criticizing the university for not doing enough to protect students from antisemitism. Early last year he launched an unsuccessful bid to get four candidates on the ballot for a governing board. REUTERS

But its cutting-edge faculty, researchers and students could easily move elsewhere, he said. “This is the best time in history to start a university.”

He also again hit out at the school’s governing board, saying it has become insular and that there is no mechanism to remove members the way there is in corporate America where investors can run board challenges.

“What happens when you have a board that can self-appoint itself, and it becomes insular, and with a $53 billion endowment, they think, okay, we can just do whatever is on our mind.”

Credit: Source link

ShareTweetSendSharePin

Related Posts

Macleods Pharma USA recalls thousands of blood pressure medication after pills fail quality test
Business

Macleods Pharma USA recalls thousands of blood pressure medication after pills fail quality test

November 3, 2026
Apple beats revenue expectations in first earnings report under new CEO John Ternus
Business

Apple beats revenue expectations in first earnings report under new CEO John Ternus

November 3, 2026
OpenAI plans to use less electricity when grid is strained at this new facility
Business

OpenAI plans to use less electricity when grid is strained at this new facility

November 2, 2026
Data-center fury is a campaign dud
Business

Data-center fury is a campaign dud

November 2, 2026
Next Post
Putin declares Easter ceasefire in Ukraine

Putin declares Easter ceasefire in Ukraine

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Cornell faculty member alleges ‘cover up’ in Jane Doe case

Cornell faculty member alleges ‘cover up’ in Jane Doe case

October 30, 2026
Credo Is Still Not Worth Buying Again

Credo Is Still Not Worth Buying Again

October 28, 2026
Rates Spark: U.S. Midterms And Expanding European Government Bond Concerns

Rates Spark: U.S. Midterms And Expanding European Government Bond Concerns

November 3, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!